At a glance
- Originator Novartis
- Class Anti-inflammatories; Antiasthmatics; Corticosteroids
- Mechanism of Action Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 20 Feb 1995 No-Development-Reported for Allergic rhinitis in Switzerland (Unknown route)
- 20 Feb 1995 No-Development-Reported for Asthma in Switzerland (Inhalation)